Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

EOM Pharmaceutical Holdings Price to Sales Ratio 2010-2018 | IMUC

Historical PS ratio values for EOM Pharmaceutical Holdings (IMUC) over the last 10 years. The current P/S ratio for EOM Pharmaceutical Holdings as of May 06, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
EOM Pharmaceutical Holdings P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2018-10-16 0.05 inf
2018-06-30 0.26 0 0.00
2018-03-31 0.25 0 0.00
2017-12-31 0.32 0 0.00
2017-09-30 0.37 0 0.00
2017-06-30 0.85 0 0.00
2017-03-31 3.18 0 0.00
2016-12-31 2.05 0 0.00
2016-09-30 4.72 0 0.00
2016-06-30 9.21 0 0.00
2016-03-31 11.60 0 0.00
2015-12-31 14.21 0 0.00
2015-09-30 16.80 0 0.00
2015-06-30 18.88 0 0.00
2015-03-31 19.40 0 0.00
2014-12-31 29.20 0 0.00
2014-09-30 35.60 0 0.00
2014-06-30 44.80 0 0.00
2014-03-31 48.80 0 0.00
2013-12-31 37.00 0 0.00
2013-09-30 102.80 0 0.00
2013-06-30 77.60 0 0.00
2013-03-31 109.60 0 0.00
2012-12-31 76.80 0 0.00
2012-09-30 112.40 0 0.00
2012-06-30 150.00 0 0.00
2012-03-31 119.60 0 0.00
2011-12-31 54.40 0 0.00
2011-09-30 62.80 0 0.00
2011-06-30 88.00 0 0.00
2011-03-31 92.00 0 0.00
2010-12-31 54.40 0 0.00
2010-09-30 36.80 0 0.00
2010-06-30 43.20 $8.20 5.27
2010-03-31 40.80 $8.20 4.98
2009-12-31 39.60 $8.20 4.83
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.000B
EOM Pharmaceuticals Inc. is a privately held, clinical-stage pharmaceutical company. It focus on advancing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal and other diseases. EOM Pharmaceuticals Inc., formerly known as ImmunoCellular Therapeutics Ltd., is based in MONTVALE, N.J.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.722B 30.79
Chugai Pharmaceutical (CHGCY) Japan $54.827B 24.51
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Merck (MKGAF) Germany $21.034B 19.85
Astellas Pharma (ALPMY) Japan $18.212B 28.75
Sandoz Group AG (SDZNY) Switzerland $14.757B 0.00
Neurocrine Biosciences (NBIX) United States $14.261B 39.04
Shionogi (SGIOY) Japan $14.151B 12.69
United Therapeutics (UTHR) United States $11.555B 12.32
Catalent (CTLT) United States $10.202B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.925B 7.61
Revolution Medicines (RVMD) United States $6.658B 0.00
Ionis Pharmaceuticals (IONS) United States $6.162B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.014B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.662B 0.00
Summit Therapeutics (SMMT) United States $3.138B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.117B 0.00
PTC Therapeutics (PTCT) United States $2.528B 0.00
Indivior (INDV) United States $2.503B 11.86
Corcept Therapeutics (CORT) United States $2.496B 22.61
Dyne Therapeutics (DYN) United States $2.294B 0.00
Ardelyx (ARDX) United States $2.141B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.098B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.042B 11.67
NewAmsterdam Pharma (NAMS) Netherlands $1.951B 0.00
Evotec AG (EVO) Germany $1.843B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.769B 18.28
Avadel Pharmaceuticals (AVDL) Ireland $1.687B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Soleno Therapeutics (SLNO) United States $1.535B 0.00
Xencor (XNCR) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.369B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.269B 11.93
Pacira BioSciences (PCRX) United States $1.233B 12.27
Collegium Pharmaceutical (COLL) United States $1.211B 7.45
BioCryst Pharmaceuticals (BCRX) United States $1.087B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Cronos Group (CRON) Canada $1.012B 0.00
Relay Therapeutics (RLAY) United States $0.937B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.932B 0.00
Cassava Sciences (SAVA) United States $0.931B 0.00
ARS Pharmaceuticals (SPRY) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.897B 0.00
USANA Health Sciences (USNA) United States $0.857B 13.90
Sage Therapeutics (SAGE) United States $0.797B 0.00
Siga Technologies (SIGA) United States $0.739B 10.94
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Savara (SVRA) United States $0.684B 0.00
Silence Therapeutics (SLN) United Kingdom $0.655B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Exscientia (EXAI) United Kingdom $0.604B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.600B 0.00
OmniAb (OABI) United States $0.552B 0.00
Verve Therapeutics (VERV) United States $0.538B 0.00
Larimar Therapeutics (LRMR) United States $0.526B 0.00
Altimmune (ALT) United States $0.522B 0.00
ProKidney (PROK) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.512B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Korro Bio (KRRO) United States $0.453B 0.00
Lexeo Therapeutics (LXEO) United States $0.435B 0.00
Heron Therapeutics (HRTX) United States $0.428B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
Esperion Therapeutics (ESPR) United States $0.402B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Black Diamond Therapeutics (BDTX) United States $0.388B 0.00
Harrow (HROW) United States $0.371B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 20.10
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Bioventus (BVS) United States $0.317B 0.00
Organogenesis (ORGO) United States $0.315B 59.75
Akebia Therapeutics (AKBA) United States $0.312B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.310B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.309B 0.00
ESSA Pharma (EPIX) Canada $0.309B 0.00
Fractyl Health (GUTS) United States $0.304B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
Nanobiotix S.A (NBTX) France $0.298B 0.00
Xeris Biopharma Holdings (XERS) United States $0.281B 0.00
Pyxis Oncology (PYXS) United States $0.254B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.245B 0.00
Metagenomi (MGX) United States $0.242B 0.00
Eliem Therapeutics (ELYM) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.230B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Zevra Therapeutics (ZVRA) United States $0.224B 0.00
Galectin Therapeutics (GALT) United States $0.215B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.214B 0.00
Century Therapeutics (IPSC) United States $0.205B 0.00
Acrivon Therapeutics (ACRV) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Telomir Pharmaceuticals (TELO) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.171B 0.00
Prelude Therapeutics (PRLD) United States $0.161B 0.00
Regulus Therapeutics (RGLS) United States $0.159B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Elite Pharmaceuticals (ELTP) United States $0.153B 14.35
CytoDyn (CYDY) United States $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.147B 0.00
Cardiol Therapeutics (CRDL) Canada $0.138B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.135B 2.84
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
OptiNose (OPTN) United States $0.129B 0.00
Inotiv (NOTV) United States $0.123B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.116B 5.30
FibroGen (FGEN) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.111B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
ProPhase Labs (PRPH) United States $0.096B 0.00
Aclaris Therapeutics (ACRS) United States $0.093B 0.00
AlloVir (ALVR) United States $0.093B 0.00
Jaguar Animal Health (JAGX) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Tempest Therapeutics (TPST) United States $0.083B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.082B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Carisma Therapeutics (CARM) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.97
Mural Oncology (MURA) Ireland $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
DURECT (DRRX) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Surrozen (SRZN) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Lyra Therapeutics (LYRA) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.20
MEI Pharma (MEIP) United States $0.021B 1.08
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Acutus Medical (AFIB) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.40
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.02